Souza DO - Search Results

1

Caffeine as a neuroprotective adenosine receptor antagonist.

Dall'Igna OP, Souza DO, Lara DR. Dall'Igna OP, et al. Among authors: souza do. Ann Pharmacother. 2004 Apr;38(4):717-8. doi: 10.1345/aph.1D307. Epub 2004 Feb 24. Ann Pharmacother. 2004. PMID: 14982979 No abstract available.

2

Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity.

Dall'Igna OP, Porciúncula LO, Souza DO, Cunha RA, Lara DR. Dall'Igna OP, et al. Among authors: souza do. Br J Pharmacol. 2003 Apr;138(7):1207-9. doi: 10.1038/sj.bjp.0705185. Br J Pharmacol. 2003. PMID: 12711619 Free PMC article.

3

Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice.

Dall'Igna OP, Fett P, Gomes MW, Souza DO, Cunha RA, Lara DR. Dall'Igna OP, et al. Among authors: souza do. Exp Neurol. 2007 Jan;203(1):241-5. doi: 10.1016/j.expneurol.2006.08.008. Epub 2006 Sep 27. Exp Neurol. 2007. PMID: 17007839

4

Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice.

Dall'Igna OP, Da Silva AL, Dietrich MO, Hoffmann A, de Oliveira RV, Souza DO, Lara DR. Dall'Igna OP, et al. Among authors: souza do. Psychopharmacology (Berl). 2003 Mar;166(3):258-63. doi: 10.1007/s00213-002-1362-1. Epub 2003 Feb 13. Psychopharmacology (Berl). 2003. PMID: 12589526

5

Effect of riluzole on MK-801 and amphetamine-induced hyperlocomotion.

Lourenço Da Silva A, Hoffmann A, Dietrich MO, Dall'Igna OP, Souza DO, Lara DR. Lourenço Da Silva A, et al. Among authors: souza do. Neuropsychobiology. 2003;48(1):27-30. doi: 10.1159/000071825. Neuropsychobiology. 2003. PMID: 12886037

6

Anticonvulsant effect of GMP depends on its conversion to guanosine.

Soares FA, Schmidt AP, Farina M, Frizzo ME, Tavares RG, Portela LV, Lara DR, Souza DO. Soares FA, et al. Among authors: souza do. Brain Res. 2004 Apr 16;1005(1-2):182-6. doi: 10.1016/j.brainres.2004.01.053. Brain Res. 2004. PMID: 15044076

7

Atypical antipsychotic profile of flunarizine in animal models.

Tort AB, Dall'Igna OP, de Oliveira RV, Mantese CE, Fett P, Gomes MW, Schuh J, Souza DO, Lara DR. Tort AB, et al. Among authors: souza do. Psychopharmacology (Berl). 2005 Jan;177(3):344-8. doi: 10.1007/s00213-004-1955-y. Epub 2004 Jul 28. Psychopharmacology (Berl). 2005. PMID: 15290004

8

Guanosine selectively inhibits locomotor stimulation induced by the NMDA antagonist dizocilpine.

Tort AB, Mantese CE, dos Anjos GM, Dietrich MO, Dall'Igna OP, Souza DO, Lara DR. Tort AB, et al. Among authors: souza do. Behav Brain Res. 2004 Oct 5;154(2):417-22. doi: 10.1016/j.bbr.2004.03.008. Behav Brain Res. 2004. PMID: 15313029

9

Increased locomotor response to amphetamine, but not other psychostimulants, in adult mice submitted to a low-protein diet.

Dietrich MO, Mantese CE, Dos Anjos GM, Rotta LN, Perry ML, Souza DO, Lara DR. Dietrich MO, et al. Among authors: souza do. Physiol Behav. 2004 Oct 30;83(1):129-33. doi: 10.1016/j.physbeh.2004.08.003. Physiol Behav. 2004. PMID: 15501499

10

Cinnarizine has an atypical antipsychotic profile in animal models of psychosis.

Dall'Igna OP, Tort AB, Souza DO, Lara DR. Dall'Igna OP, et al. Among authors: souza do. J Psychopharmacol. 2005 Jul;19(4):342-6. doi: 10.1177/0269881105053284. J Psychopharmacol. 2005. PMID: 15982988

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

559 results

Search Page

Filters